HE ability of the mammalian PNS to regenerate axons after injury is well documented. The most characteristic feature of wallerian degeneration and subsequent regeneration is the proliferation and activation of Schwann cells within the distal nerve stump, which results in the formation of Schwann cell cordons (based on the original observations of Waller in 1850; see also Hall 11 ). Peripheral nervous system regeneration occurs mainly through a series of reactions produced by activated Schwann cells so that the axons of the proximal nerve stump grow through the distal stump in close contact with the Schwann cell bands. 24 Clearly, the Schwann cells produce a large variety of neurotrophic factors and cytokines and express cell adhesion molecules and extracellular molecules known to support axonal regeneration. 4, 7, 8, 13, 19, 21, 28 As a result of these integrated functions, nerve regeneration can be induced and the reinnervated Schwann cells can revert to an axon-associated phenotype, namely myelin-forming cells.
cell types such as osteoblasts, adipocytes, chondrocytes, and cardiac muscle cells. 6, 15, 20, 23, 26 Bone marrow stromal cells are promising candidates for clinical applications because they are easy to isolate from bone marrow aspirates without posing major ethical problems and because they are readily expanded in vitro for use in autologous transplantation. Recently, we reported that BMSCs can be induced to differentiate into Schwann cells by sequentially treating the cells with several reagents and trophic factors: first with BME, followed by RA, and then culturing in the presence of forskolin (a reagent known to increase the level of intracellular cyclic adenosine monophosphate), basic fibroblast growth factor, platelet-derived growth factor-AA, and heregulin-␤1. 5 In this study, we made a long distance gap in the sciatic nerve in adult rats and transplanted BMSC-DSCs into the gap to evaluate the usefulness of these cells in PNS reconstruction based on motor function and electrophysiological and histological analyses. Because BMSCs are multipotential cells and have the ability to differentiate into several types of cells, there is reason for concern regarding tumor formation after engraftment. Hence, we undertook a long-term study in which we assessed the character of transplanted BMSCs for up to 6 months after transplantation.
Materials and Methods

Differentiation of BMSCs Into Schwann Cells
Bone marrow stromal cells were isolated from male Wistar rats 6 weeks after birth. They were then infected with pBabe-neoenhanced GFP retrovirus to label the cells with GFP. Inducing Schwann cells to differentiate from BMSCs to produce cells referred to as BMSC-DSCs was performed as described previously. 5 In brief, BMSCs were incubated with ␣-MEM containing 1 mM BME for 24 hours. After washing with 0.1 M PBS (pH 7.4), the medium was replaced with ␣-MEM containing 10% fetal bovine serum and 35 ng/ml all-trans-RA (Sigma Chemical Co., St. Louis, MO) for 3 days. Cells were then transferred to ␣-MEM containing 10% fetal bovine serum, 5 M forskolin (Calbiochem, La Jolla, CA), 10 ng/ml recombinant human basic fibroblast growth factor (Peprotech, London, UK), 5 ng/ml platelet-derived growth factor-AA (Peprotech), and 200 ng/ml heregulin-␤1 (R&D Systems, Minneapolis, MN) for 7 days and were used for the transplantation. The differentiation of BMSCs into Schwann cells was confirmed in vitro by immunocytochemical analysis of p75, glial fibrillary acidic protein, and S100 protein, all of which are known to be expressed in Schwann cells. 5 
Transplantation With BMSC-DSCs
The animal study was approved by the Ethics Committee for Animal Experiments at Yokohama City University Graduate School of Medicine.
For the BMSC-DSC group, differentiated cells were suspended in Matrigel (Collaborative Biomedical Products, Bedford, MA) at a concentration of 1 to 2 ϫ 10 7 cells/ml and were transferred into Diafro hollow fibers (Amicon, Beverly, MA). For the control group, grafts were made with Matrigel alone and did not contain BMSCDSCs. Adult male Wistar rats weighing 250 to 300 g were anesthetized (intraperitoneal injection of 50 mg/kg sodium pentobarbital). The right sciatic nerve was completely transected at the sciatic notch and a 12-mm-long segment of the distal portion of the nerve was dissected. Artificial grafts (12 mm long) were interposed into the gap between the proximal and distal segments and were anastomosed using 10-0 nylon strings at both ends. After the operation, the rats received adequate exercise and stretching every 3 days to prevent joint contracture. Five rats were used in the BMSC-DSC group and eight in the control group.
Walking Track Analysis
Behavior analysis was performed through the assessment of walking patterns in the lower limb, following a previously reported method. 3, 12 A piece of x-ray film was placed in the bottom of a corridor (85 ϫ 450 mm). The rat's hind feet were dipped in x-ray developer, and the rat was permitted to walk down the corridor so that its footprints could be recorded. Walking track analysis in each rat was performed 1, 3, and 5 months after the operation. The PL (third toe to heel), TS (first to fifth toe), and ITS (second to fourth toe) were measured on the experimental (E) side (EPL, ETS, and EITS, respectively) and the contralateral normal (N) side (NPL, NTS, and NITS, respectively). The SNFI was calculated as follows: SNFI = Ϫ 38.3 ϫ (EPL Ϫ NPL)/NPL ϩ 109.5 ϫ (ETS Ϫ NTS)/NTS ϩ 13.3 ϫ (EITS Ϫ NITS)/NITS Ϫ 8.8. According to a previous report, 3 the normal range for SNFI is Ϫ1.9 Ϯ 6.3.
Electrophysiological Study: Measurement of MNCV
The MNCV was measured 6 months after the operation. Rectal temperature was maintained between 37 and 37.5˚C by using a feedback-regulated heating pad (BWT-100; Bio Research Center, Nagoya, Japan) during the procedure, and an electromyograph (Synax; NEC Sanei, Tokyo, Japan) was used for the recording. Briefly, with the rat in a state of general anesthesia (intraperitoneal injection of 50 mg/kg sodium pentobarbital), the right sciatic nerve (transplanted side) was exposed and directly stimulated at the distal end of the proximal sciatic nerve segment by using bipolar hook-shaped electrodes. Stimulation consisted of single 0.2-msec supramaximal (intensity 0.4 mA) pulses, and the M wave was recorded (electromyogram) at the first interosseous muscle via unipolar needle electrodes. A ground was placed on a muscle between the two electrodes. Next, the distal nerve was directly stimulated at the Achilles tendon and the M wave was also recorded. The MNCV was calculated by dividing the distance between two stimulating points by the time interval; it was measured three times for each rat. The MNCV of the left sciatic nerve (contralateral intact side) was also measured and the %MNCV (the ratio of the MNCV on the transplanted side to that on the intact side) was calculated.
Immunohistochemical Analysis
After the MNCV measurement, 6 l CTX (0.5 mg/25 l distilled water; LIST Biological Laboratories, Inc., Campbell, CA) was injected into the proximal sciatic nerve segment (1 cm proximal to the transected end). After 1 week, the rats were perfused transcardially with periodate-lysine-paraformaldehyde fixative solution. 22 The sciatic nerve, graft, and innervating muscle (the first interosseous muscle) were dissected. They were immersed in the same fixative solution for 6 hours and washed with 0.1 M PBS. Ten-micrometer frozen sections of both the graft and the interosseous muscle were made. For immunostaining, the following primary antibodies were used: anti-MAG (1:20; Boehringer Mannheim, Mannheim, Germany), anti-NF M (1:200; Boehringer Mannheim), anti-P0 (1:1000; kindly provided by Dr. J. J. Archelos, Karl-Franzens Universitat, Graz, Austria), anti-CTX (1:2000; LIST Biological Laboratories, Inc.), and anti-VACHT (1:500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Sections were incubated with primary antibodies overnight at 4˚C, washed with PBS, and incubated with secondary antibodies (either Alexa Fluor 546-conjugated anti-mouse IgG or rabbit IgG; Molecular Probes, Eugene, OR) for 1 hour at room temperature. For anti-CTX, biotinylated antigoat IgG was used as the secondary antibody, followed by avidinbiotin complex incubation (VectaStain; Vector Laboratories, Inc., Burlingame, CA), with final detection by Alexa Fluor 633-conjugated streptavidin (Molecular Probes). Sections were inspected using a confocal laser scanning microscope (Radiance 2000; BioRad, Hertfordshire, UK). To measure regenerated axons, transverse sections from the central portion of the graft were prepared and stained with anti-NF antibody. The number of NF-positive axons was counted in each section.
Statistical Analysis
The mean Ϯ standard deviation was calculated and analyzed based on a one-tailed nonpaired Student t-test by using statistical software (Statistica; StatSoft, Inc., Tulsa, OK).
Results
Macroscopic Observations
Six months after transplantation, anastomosis between the graft and sciatic nerve segment was tight, and some proliferation of the connective tissue was observed at the anastomotic site in the BMSC-DSC group. Although new whitish parenchymatous tissue was found within thelumen of the hollow fiber in both the control and BMSC-DSC groups, the tissues in the BMSC-DSC group were more stable and consistently connected to both the proximal and distal peripheral nerve segments (Fig. 1) . Tumorigenesis was not observed in the graft and sciatic nerve segment.
FIG. 1. Photograph (upper)
and schematic (lower) demonstrating an exposed grafted sciatic nerve and the wall of hollow fiber partially removed in the BMSC-DSC group 6 months after transplantation. Newly regenerated tissue was found within the lumen (arrows). The wall of the hollow fiber (arrowheads), the proximal segment (asterisk), and the distal segment (double asterisks) of the transected sciatic nerve are indicated.
Walking Track Analysis
The SNFI was measured at 1, 3, and 5 months after transplantation. Both the control and BMSC-DSC groups showed gradual improvement after the surgery, and the mean SNFI in the BMSC-DSC group tended to be higher than that in the control group at 1, 3, and 5 months (Fig.  2) . The mean SNFI after 5 months was Ϫ65.29 Ϯ 13.43 and Ϫ79.77 Ϯ 4.12 (mean Ϯ standard deviation) in the control and BMSC-DSC groups, respectively, and the difference was statistically significant (p = 0.03).
Electrophysiological Study
In the electrophysiological study, the M wave was recorded after stimulation of the sciatic nerve in both the control and BMSC-DSC groups 6 months after surgery (Fig. 3A and B) . The mean MNCV was 24.05 Ϯ 5.85 m/second in the control group and 31.89 Ϯ 3.23 m/second in the BMSC-DSC group. The difference between these values was statistically significant (p = 0.011; Fig. 4A ). The %MNCVs were 45.54 Ϯ 11.06% and 66.87 Ϯ 13.15% in the control and BMSC-DSC groups, respectively, showing a highly significant difference (p = 0.006; Fig. 4B ).
Histological Study
Prior to transplantation, almost all of the induced cells in vitro were positive for Schwann cell markers such as p75, glial fibrillary acidic protein, and S100 (data not shown).
In the control group, although migration of host original Schwann cells was recognized within the graft, a small number of regenerated axons were also observed (data not shown). In the BMSC-DSC group, GFP-positive cells were rich in regenerated parenchymatous tissue, and NFpositive myelinated axons were abundant in the central portion of the graft (Fig. 5a ). These GFP-positive BMSCs were immunopositive for P0 and MAG ( Fig. 5b and d) , both of which are known to be markers of mature myelinforming Schwann cells. The formation of nodes of Ranvier was also observed. Regenerated axons were anterogradely labeled with CTX at the proximal sciatic nerve segment. These labeled axons were surrounded by P0-and MAG-expressing GFP-positive BMSCs, showing that the transplanted cells existed within the graft for 6 months with the histological and morphological characteristics of differentiated mature Schwann cells (Fig. 5b-d) . The CTX traced out the regenerated nerve by axonal transportation to the neuromuscular junction of the first interosseous muscle, showing that CTX-labeled regenerated sciatic nerve axons are VACHT-positive cholinergic motor nerves (Fig. 5e) . Inspection of the transverse axial section in the central portion of the graft showed that the density of regenerated axons was lower in the control group compared with that in the BMSC-DSC group (Fig.  6) . The difference in the number of regenerated axons per section in the central portion of the graft was highly significant when comparing the control and BMSC-DSC groups (p = 0.00005).
Discussion
Schwann cells are known to promote regeneration of an injured peripheral nerves. 4, 8, 13, 19, 21, 28 Data from several studies of artificial nerve grafts made from Schwann cells have been reported, and analysis of these data has demonstrated successful regeneration of nerve axons. 1,10,14,16-18, 25,27 In this study, we used BMSC-DSCs, instead of original primary Schwann cells, and showed that they have the ability to promote regeneration and remyelination of damaged nerve axons.
Inducing BMSCs to Differentiate Into Schwann Cells
Differentiation of BMSCs into Schwann cells can be achieved without any genetic manipulation, but simply with the administration of the reagents BME, RA, forskolin, and trophic factors, thus providing an advantage in therapeutic applications in humans. Nonetheless, BMSCs have multiple differentiation properties and great proliferative potential, and the BME and RA used during BMSC-DSC formation are carcinogenic substances. Hence, concerns regarding tumorigenesis cannot be excluded, although no pathological findings were observed in vivo, even 6 months after transplantation.
Effectiveness of BMSC-DSC Transplantation
Matrigel, which was used as the cell suspension material, contains laminin, collagen IV, transforming growth factor-␤, and fibroblast growth factor. These substances are known to promote regeneration of peripheral nerves to a certain extent. Hence, some nerve regeneration could be observed in the control experiment by using a graft containing Matrigel only. Furthermore, the Schwann cells found within the graft in the control group probably migrated from both proximal and distal nerve stumps. These original Schwann cells sustained regeneration in the control group so that the time required for the proliferation and migration of the Schwann cells from both nerve ends influenced the ratio of nerve regeneration when the control and BMSC-DSC groups were compared. In the BMSC-DSC group, on the other hand, abundant Schwann cells were already supplied within the graft, which led to faster and more abundant regeneration, myelination formation, and functional recovery. 
Histological, Behavioral, and Electrophysiological Studies
Six months after transplantation, many regenerated nerve fibers were found within the graft in the BMSC-DSC group. Regenerated sciatic nerve axons were anterogradely labeled with CTX, and these axons were VACHTpositive at the neuromuscular junctions. Moreover, many of the axons were remyelinated by GFP-labeled BMSCs expressing the Schwann cell-specific markers MAG and P0, 2 thus indicating that the transplanted BMSC-DSCs kept the differentiated phenotype within the graft for at least 6 months. Compatible with these histological observations, results of the electrophysiological study showed a higher mean MNCV in the BMSC-DSC group than in the control group 6 months after transplantation. In the walking track analysis, SNFI improvement occurred in the BMSC-DSC group 5 months after transplantation, although ankle contracture was observed in both the BMSC-DSC and control groups despite adequate exercise and stretching. This means that musculoskeletal sequelae of complete denervation cannot be prevented by the strong regenerative effect of BMSC-DSCs. The SNFI formula is composed of PL, TS, and ITS. Ankle contracture had a great influence on PL; however, other joints in the paw did not show contracture. We think that the improvements in TS and ITS contributed to the statistical difference in SNFI in a comparison between the BMSC-DSC and control groups.
Future Clinical Applications
In current clinical practice, compression or partially transected nerve injury can be treated nonsurgically. On the other hand, a completely transected nerve usually requires nerve suture. Primary direct perineural suture is applicable for a short distance gap, and autologous nerve grafts from the sural nerve or anterobrachial cutaneous nerve are available for bypassing long distance gaps that are untreatable by primary tensionless repair. Nonetheless, these autologous nerve grafts have limitations in their application as longer grafts or as grafts of varying diameter. Accordingly, artificial nerve grafts would solve these problems.
The BMSCs are a very good source for supplying donor cells and may be a solution to current limitations in autotransplantation because they have great proliferative potential in humans as well as in rats. Other merits of using BMSCs as donor cells are as follows: bone marrow harvesting is relatively less invasive, the method is free from foreign pathogen interference, there is no need for immunosuppressive therapy, and there are no ethical problems. Considering future clinical applications, autotransplantation will be possible if there is enough time to induce BMSCs to differentiate into Schwann cells. If acute transplantation is necessary for the treatment of an injured peripheral nerve, however, a viable alternative is the use of Schwann cells from BMSCs donated by other persons, even though immunosuppressive therapy is indispensable.
Improvements in inducing differentiation from primary BMSCs to specific cells will contribute to greater efficacy of cell transplantation, and our experiments are a prologue to the development of artificial nerve grafts. We anticipate that the use of BMSCs will serve as one of the solutions to the difficulty in reconstructing long distance gaps in peripheral nerves.
Conclusions
In this study we made artificial grafts filled with BMSC-DSCs and transplanted them into transected sciatic nerves in adult rats. Six months after cell transplantation, electrophysiological evaluation and walking track analysis were performed and revealed significant improvement in motor nerve conduction velocity and SNFI in the BMSC-DSC-transplanted group compared with the control group. showed that transplanted BMSCs labeled with retrovirus GFP were positive for P0 and MAG and had reconstructed nodes of Ranvier and remyelinated regenerated nerve axons. The number of regenerated axons in the axial section of the central portion of the graft was significantly greater in the transplanted group. Although BMSCs can differentiate into several types of cells, tumor formation was not found 6 months after the engraftment procedure. The BMSC-DSCs have great potential as an alternative method for the difficult reconstruction of a long distance gap in a peripheral nerve.
